Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
Illumina, a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics […]
Celyad Oncology Appoints Georges Rawadi as Its New CEO
Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]
Companion Spine Closes $60.1 Million Series A Funding Round
Companion Spine, the French-American specialist in interventional spine pain-management surgery, today announced the successful closing […]
EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis
EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer
Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]
GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare
GT Medical Technologies, a medical device company dedicated to improving the lives of patients with […]
Genprex CEO Commends FDA's Initiative to Accelerate Approval Process for Gene Therapies
Rodney Varner, CEO of Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies […]
OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia
OliX Pharmaceuticals, a leading developer of RNAi therapeutics, announced today that it has received approval […]
Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer
Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]
BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases
BIOTECanada welcomes the government’s dedicated investment of $1.5 B over 3 years to advance effective […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more